Gpcr

Gpcr

Innovative therapeutics targeting GPCRs to treat complex diseases with precision medicine.

HQ location
South Korea
Website
Launch date
Employees
Enterprise value
$88m
Company register number
1148712922
  • Edit
Get premium to view all results
DateInvestorsAmountRound
-investor investor investor investor

€0.0

round
investor

€0.0

round
N/A

€0.0

round
*

KRW4.1b

Valuation: KRW105.0b

Late VC
Total Funding000k
Notes (0)
More about Gpcr
Made with AI
Edit

GPCR Therapeutics, Inc. is a biotechnology company specializing in the development of innovative therapeutics targeting G protein-coupled receptors (GPCRs) to treat complex diseases. The company operates in the biopharmaceutical market, focusing on precision medicine to address unmet medical needs. GPCR Therapeutics serves a diverse range of clients, including pharmaceutical companies, healthcare providers, and research institutions. The business model revolves around research and development (R&D) of novel drugs, leveraging proprietary technology to discover and develop new treatments. Revenue is generated through partnerships, licensing agreements, and the commercialization of its therapeutic products. The company is led by a team of experienced professionals with extensive backgrounds in biotechnology, pharmaceuticals, and financial management.

Keywords: GPCRs, therapeutics, precision medicine, biotechnology, biopharmaceutical, drug development, R&D, partnerships, licensing, commercialization.

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Book a Demo